Search Results
Overview
| Uniprot ID | P02649 |
|---|---|
| Protein Name | Apolipoprotein E |
| Gene Name | APOE |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position | Flanking peptide |
|---|---|
| 113 | ETRARLSKELQAAQA |
| 251 | RDRLDEVKEQVAEVR |
| 260 | QVAEVRAKLEEQAQQ |
| 87 | ALMDETMKELKAYKS |
| 93 | MKELKAYKSELEEQL |
Function
APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids (PubMed:14754908, PubMed:1911868, PubMed:6860692). APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance (PubMed:14754908, PubMed:1911868, PubMed:1917954, PubMed:23620513, PubMed:2762297, PubMed:6860692, PubMed:9395455). Apolipoproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma (PubMed:2762297, PubMed:6860692, PubMed:9395455). As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but shows a preferential binding to high-density lipoproteins (HDL) (PubMed:1911868, PubMed:6860692). It also binds a wide range of cellular receptors including the LDL receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8 and the very low-density lipoprotein receptor/VLDLR that mediate the cellular uptake of the APOE-containing lipoprotein particles (PubMed:12950167, PubMed:1530612, PubMed:1917954, PubMed:20030366, PubMed:20303980, PubMed:2063194, PubMed:2762297, PubMed:7635945, PubMed:7768901, PubMed:8756331, PubMed:8939961). Finally, APOE also has a heparin-binding activity and binds heparan-sulfate proteoglycans on the surface of cells, a property that supports the capture and the receptor-mediated uptake of APOE-containing lipoproteins by cells (PubMed:23676495, PubMed:7635945, PubMed:9395455, PubMed:9488694). A main function of APOE is to mediate lipoprotein clearance through the uptake of chylomicrons, VLDLs, and HDLs by hepatocytes (PubMed:1911868, PubMed:1917954, PubMed:23676495, PubMed:29516132, PubMed:9395455). APOE is also involved in the biosynthesis by the liver of VLDLs as well as their uptake by peripheral tissues ensuring the delivery of triglycerides and energy storage in muscle, heart and adipose tissues (PubMed:2762297, PubMed:29516132). By participating in the lipoprotein-mediated distribution of lipids among tissues, APOE plays a critical role in plasma and tissues lipid homeostasis (PubMed:1917954, PubMed:2762297, PubMed:29516132). APOE is also involved in two steps of reverse cholesterol transport, the HDLs-mediated transport of cholesterol from peripheral tissues to the liver, and thereby plays an important role in cholesterol homeostasis (PubMed:14754908, PubMed:23620513, PubMed:9395455). First, it is functionally associated with ABCA1 in the biogenesis of HDLs in tissues (PubMed:14754908, PubMed:23620513). Second, it is enriched in circulating HDLs and mediates their uptake by hepatocytes (PubMed:9395455). APOE also plays an important role in lipid transport in the central nervous system, regulating neuron survival and sprouting (PubMed:25173806, PubMed:8939961). APOE is also involved in innate and adaptive immune responses, controlling for instance the survival of myeloid-derived suppressor cells (By similarity). Binds to the immune cell receptor LILRB4 (PubMed:30333625). APOE may also play a role in transcription regulation through a receptor-dependent and cholesterol-independent mechanism, that activates MAP3K12 and a non-canonical MAPK signal transduction pathway that results in enhanced AP-1-mediated transcription of APP (PubMed:28111074)
Protein Sequence
Gene Ontology
| Classification | GO ID | Description |
|---|---|---|
| Cellular Component | GO:0072562 | blood microparticle |
| Cellular Component | GO:0042627 | chylomicron |
| Cellular Component | GO:0034360 | chylomicron remnant |
| Cellular Component | GO:0030669 | clathrin-coated endocytic vesicle membrane |
| Cellular Component | GO:0005737 | cytoplasm |
| Cellular Component | GO:0030425 | dendrite |
| Cellular Component | GO:0034365 | discoidal high-density lipoprotein particle |
| Cellular Component | GO:0005769 | early endosome |
| Cellular Component | GO:0071682 | endocytic vesicle lumen |
| Cellular Component | GO:0005783 | endoplasmic reticulum |
| Cellular Component | GO:0005788 | endoplasmic reticulum lumen |
| Cellular Component | GO:0070062 | extracellular exosome |
| Cellular Component | GO:0031012 | extracellular matrix |
| Cellular Component | GO:0005576 | extracellular region |
| Cellular Component | GO:0005615 | extracellular space |
| Cellular Component | GO:1903561 | extracellular vesicle |
| Cellular Component | GO:0098978 | glutamatergic synapse |
| Cellular Component | GO:0005794 | Golgi apparatus |
| Cellular Component | GO:0034364 | high-density lipoprotein particle |
| Cellular Component | GO:0034363 | intermediate-density lipoprotein particle |
| Cellular Component | GO:1990777 | lipoprotein particle |
| Cellular Component | GO:0034362 | low-density lipoprotein particle |
| Cellular Component | GO:0042470 | melanosome |
| Cellular Component | GO:0016020 | membrane |
| Cellular Component | GO:0097487 | multivesicular body, internal vesicle |
| Cellular Component | GO:0043025 | neuronal cell body |
| Cellular Component | GO:0005634 | nucleus |
| Cellular Component | GO:0005886 | plasma membrane |
| Cellular Component | GO:0043083 | synaptic cleft |
| Cellular Component | GO:0034361 | very-low-density lipoprotein particle |
| Molecular Function | GO:0001540 | amyloid-beta binding |
| Molecular Function | GO:0016209 | antioxidant activity |
| Molecular Function | GO:0120020 | cholesterol transfer activity |
| Molecular Function | GO:0019899 | enzyme binding |
| Molecular Function | GO:0043395 | heparan sulfate proteoglycan binding |
| Molecular Function | GO:0008201 | heparin binding |
| Molecular Function | GO:0042802 | identical protein binding |
| Molecular Function | GO:0008289 | lipid binding |
| Molecular Function | GO:0005319 | lipid transporter activity |
| Molecular Function | GO:0071813 | lipoprotein particle binding |
| Molecular Function | GO:0050750 | low-density lipoprotein particle receptor binding |
| Molecular Function | GO:0046911 | metal chelating activity |
| Molecular Function | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity |
| Molecular Function | GO:0005543 | phospholipid binding |
| Molecular Function | GO:0046983 | protein dimerization activity |
| Molecular Function | GO:0042803 | protein homodimerization activity |
| Molecular Function | GO:0044877 | protein-containing complex binding |
| Molecular Function | GO:0048018 | receptor ligand activity |
| Molecular Function | GO:0005102 | signaling receptor binding |
| Molecular Function | GO:0005198 | structural molecule activity |
| Molecular Function | GO:0048156 | tau protein binding |
| Molecular Function | GO:0070326 | very-low-density lipoprotein particle receptor binding |
| Biological Process | GO:0055090 | acylglycerol homeostasis |
| Biological Process | GO:0097113 | AMPA glutamate receptor clustering |
| Biological Process | GO:0042982 | amyloid precursor protein metabolic process |
| Biological Process | GO:0071402 | cellular response to lipoprotein particle stimulus |
| Biological Process | GO:0033344 | cholesterol efflux |
| Biological Process | GO:0042632 | cholesterol homeostasis |
| Biological Process | GO:0008203 | cholesterol metabolic process |
| Biological Process | GO:0034382 | chylomicron remnant clearance |
| Biological Process | GO:0007010 | cytoskeleton organization |
| Biological Process | GO:0055089 | fatty acid homeostasis |
| Biological Process | GO:0007186 | G protein-coupled receptor signaling pathway |
| Biological Process | GO:0034380 | high-density lipoprotein particle assembly |
| Biological Process | GO:0034384 | high-density lipoprotein particle clearance |
| Biological Process | GO:0034375 | high-density lipoprotein particle remodeling |
| Biological Process | GO:0044794 | host-mediated activation of viral process |
| Biological Process | GO:0071831 | intermediate-density lipoprotein particle clearance |
| Biological Process | GO:0046907 | intracellular transport |
| Biological Process | GO:0010877 | lipid transport involved in lipid storage |
| Biological Process | GO:0042158 | lipoprotein biosynthetic process |
| Biological Process | GO:0035641 | locomotory exploration behavior |
| Biological Process | GO:0015909 | long-chain fatty acid transport |
| Biological Process | GO:0007616 | long-term memory |
| Biological Process | GO:0034374 | low-density lipoprotein particle remodeling |
| Biological Process | GO:0032438 | melanosome organization |
| Biological Process | GO:1905907 | negative regulation of amyloid fibril formation |
| Biological Process | GO:1902430 | negative regulation of amyloid-beta formation |
| Biological Process | GO:0030195 | negative regulation of blood coagulation |
| Biological Process | GO:0043537 | negative regulation of blood vessel endothelial cell migration |
| Biological Process | GO:0090090 | negative regulation of canonical Wnt signaling pathway |
| Biological Process | GO:0045541 | negative regulation of cholesterol biosynthetic process |
| Biological Process | GO:0010596 | negative regulation of endothelial cell migration |
| Biological Process | GO:0001937 | negative regulation of endothelial cell proliferation |
| Biological Process | GO:0010629 | negative regulation of gene expression |
| Biological Process | GO:0050728 | negative regulation of inflammatory response |
| Biological Process | GO:1900272 | negative regulation of long-term synaptic potentiation |
| Biological Process | GO:0043409 | negative regulation of MAPK cascade |
| Biological Process | GO:0010977 | negative regulation of neuron projection development |
| Biological Process | GO:0010544 | negative regulation of platelet activation |
| Biological Process | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway |
| Biological Process | GO:0051248 | negative regulation of protein metabolic process |
| Biological Process | GO:0050709 | negative regulation of protein secretion |
| Biological Process | GO:0048662 | negative regulation of smooth muscle cell proliferation |
| Biological Process | GO:0031175 | neuron projection development |
| Biological Process | GO:0038060 | nitric oxide-cGMP-mediated signaling |
| Biological Process | GO:0097114 | NMDA glutamate receptor clustering |
| Biological Process | GO:0033700 | phospholipid efflux |
| Biological Process | GO:1905908 | positive regulation of amyloid fibril formation |
| Biological Process | GO:1900223 | positive regulation of amyloid-beta clearance |
| Biological Process | GO:0010875 | positive regulation of cholesterol efflux |
| Biological Process | GO:0090205 | positive regulation of cholesterol metabolic process |
| Biological Process | GO:0060999 | positive regulation of dendritic spine development |
| Biological Process | GO:1902952 | positive regulation of dendritic spine maintenance |
| Biological Process | GO:0045893 | positive regulation of DNA-templated transcription |
| Biological Process | GO:0045807 | positive regulation of endocytosis |
| Biological Process | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
| Biological Process | GO:0046889 | positive regulation of lipid biosynthetic process |
| Biological Process | GO:1903002 | positive regulation of lipid transport across blood-brain barrier |
| Biological Process | GO:0140077 | positive regulation of lipoprotein transport |
| Biological Process | GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process |
| Biological Process | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis |
| Biological Process | GO:0010976 | positive regulation of neuron projection development |
| Biological Process | GO:0045429 | positive regulation of nitric oxide biosynthetic process |
| Biological Process | GO:1902995 | positive regulation of phospholipid efflux |
| Biological Process | GO:0017038 | protein import |
| Biological Process | GO:0006898 | receptor-mediated endocytosis |
| Biological Process | GO:1905906 | regulation of amyloid fibril formation |
| Biological Process | GO:1902991 | regulation of amyloid precursor protein catabolic process |
| Biological Process | GO:1900221 | regulation of amyloid-beta clearance |
| Biological Process | GO:0042981 | regulation of apoptotic process |
| Biological Process | GO:0030516 | regulation of axon extension |
| Biological Process | GO:2000822 | regulation of behavioral fear response |
| Biological Process | GO:0032489 | regulation of Cdc42 protein signal transduction |
| Biological Process | GO:1905890 | regulation of cellular response to very-low-density lipoprotein particle stimulus |
| Biological Process | GO:0090181 | regulation of cholesterol metabolic process |
| Biological Process | GO:0045088 | regulation of innate immune response |
| Biological Process | GO:0048168 | regulation of neuronal synaptic plasticity |
| Biological Process | GO:0061136 | regulation of proteasomal protein catabolic process |
| Biological Process | GO:0051246 | regulation of protein metabolic process |
| Biological Process | GO:0043254 | regulation of protein-containing complex assembly |
| Biological Process | GO:0061771 | response to caloric restriction |
| Biological Process | GO:0000302 | response to reactive oxygen species |
| Biological Process | GO:0001523 | retinoid metabolic process |
| Biological Process | GO:0043691 | reverse cholesterol transport |
| Biological Process | GO:0007271 | synaptic transmission, cholinergic |
| Biological Process | GO:0070328 | triglyceride homeostasis |
| Biological Process | GO:0006641 | triglyceride metabolic process |
| Biological Process | GO:0071830 | triglyceride-rich lipoprotein particle clearance |
| Biological Process | GO:0034447 | very-low-density lipoprotein particle clearance |
| Biological Process | GO:0034372 | very-low-density lipoprotein particle remodeling |
| Biological Process | GO:0019068 | virion assembly |
Reference
[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.
[2] Lin Y, Chen M, Wang D, Yu Y, Chen R et al.. Multi-Proteomic Analysis Reveals the Effect of Protein Lactylation on Matrix and Cholesterol Metabolism in Tendinopathy.. J Proteome Res 22(6):1712-1722. 2023 Jun 2. PMID: 37159428.
[3] Yang YH, Wang QC, Kong J, Yang JT, Liu JF. Global profiling of lysine lactylation in human lungs.. Proteomics 23(15):e2200437. 2023 Aug. PMID: 37170646.